Mathias Jucker
Mathias Jucker is a neurobiologist and researcher at the German Center for Neurodegenerative Diseases in Tübingen, specializing in Alzheimer’s disease. He has been actively involved in the exploration of antibody treatments and their potential for preventing dementia. Jucker is optimistic about the future of Alzheimer's research, particularly regarding the identification of toxic protein aggregates that contribute to nerve cell death, and he advocates for early screening and intervention.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 1 | 7.00 | 0.09% | +0% | 8,654,622 | 7,474 | $700,000 | 604$ |
| Totals | 1 | 8,654,622 | 7,474 | $700,000 | 604$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Mathias Jucker has been waiting for a breakthrough in Alzheimer's research for half of his research life.
7
Switzerland:
Mathias Jucker from the German Center for Neurodegenerative Diseases in Tübingen explains the potential risks and benefits of new antibody treatments for Alzheimer's patients.
5